TAG:
cap
Preparing for the Unexpected and Unimagined
WHO WOULD HAVE EVER PREDICTED THAT A PHLEBOTOMIST would reuse needles? Just as surprising, who would have ever predicted that the phlebotomist would be working at a respected clinical laboratory like SmithKline Beecham Clinical Laboratories (SBCL)? …
Labs Entering New Cycle Of Evolution and Change
CEO SUMMARY: As some of the nation’s most astute and forward-looking lab executives prepare to gather in New Orleans for the fourth annual EXECUTIVE WAR COLLEGE, it is time to share our assessment of the laboratory and pathology industry. Recent events presage another profound …
SBCL Phlebotomist Found Reusing Needles in Calif.
CEO SUMMARY: News that a phlebotomist employed by SmithKline Beecham Clinical Laboratories (SBCL) was discovered to be washing and reusing needles got national media attention last week. During her 22-month employment at SBCL, this phlebotomist apparently reused butterfly needles on “di…
Crises Management Plan Essential for Every Lab
CEO SUMMARY: “It can’t happen here” is not good management. All clinical laboratories and pathology practices should anticipate the worst and develop their own internal controls to prevent the unthinkable and prepare for the unexpected. Rogue phlebotomists like the one at SmithKline…
Lab Contracts Priced Below Cost May be Defined as Inducement
PROBABLY THE MOST SERIOUS problem in the lab industry is one of its own making. “Below cost” contracting is a practice where clinical laboratories offer the managed care company a price which is less than its cost to provide the testing. With laboratory overcapacity still abundant in many cities…
Unilab Signs Agreement To Buy Bio-Cypher Labs
CEO SUMMARY: Unilab’s desire to purchase $60 million Bio-Cypher must be viewed against the impending acquisition by Quest Diagnostics of SmithKline Beecham Clinical Laboratories (SBCL). Whenever Quest takes control of SBCL’s lab operations, it automatically becomes a significant compe…
Client Service and Sales Fuel Fast Growth at AML
CEO SUMMARY: Here’s proof positive that effective management can make a positive difference in the financial performance of clinical labs. Upon taking title to American Medical Laboratories in the spring of 1997, its new owners used an emphasis on “customer-first” service and aggres…
Management Execution Part of AML’s Success
CEO SUMMARY: Swift and positive changes at American Medical Laboratories (AML) came as a direct result of energetic management. AML provides lab executives with an outstanding case study of how to take an existing, somewhat tranquil lab organization and turn it into a high-performance rev…
Neuromedical Systems Files Bankruptcy Action
CEO SUMMARY: Automated cytology technology suffered its first financial failure. Escalating losses and dismal revenue prospects combined to drive Neuromedical Systems, Inc. into bankruptcy. Its PapNet System for Pap smears was a pioneering technology that never achieved market acceptance….
AutoCyte to Buy NSI’s Patents and Other Assets
CEO SUMMARY: When Neuromedical Systems entered Chapter 11 bankruptcy, AutoCyte moved rapidly to purchase Neuromedical’s patents and other intellectual property for automated cytology technology. Even as Neuromedical disappears from the marketplace, AutoCyte is preparing its entry. Labor…
CURRENT ISSUE
Volume XXXII, No. 15 – October 27, 2025
The Dark Report examines the momentous decision by the VA to switch accreditors from The Joint Commission to CAP. Also, we analyze retractions in pathology journals to gain insight into scientific fraud.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.